Manipal Health Enterprises IPO: GMP, Date, Price Band, Other Important Details in 10 Points

Manipal Health Enterprises IPO: The initial public offering (IPO) of multi-specialty hospital operator, Manipal Health Enterprises, is set to open for bookings on Wednesday, July 29.

Yes ₹9,275 crore issue including fresh issue of 13.56 crore shares and offer for sale (OFS) of 2.16 crore shares.

At the same time, the trend of the gray market indicates the interest of investors in Manipal Health Enterprises IPO, as shares of the gray market (GMP) of Manipal Health shares have shown signs that it can be shown at a premium to the price of the issue.

Manipal Health Enterprises ipo gmp

Manipal Health Enterprises’ IPO GMP on Tuesday morning was ₹13, recommended stocks can be shown at a premium of 2% to the issue price. GMP of the stock has decreased from the level of the previous meeting ₹25.

Manipal Health Enterprises IPO Key Details

1. Manipal Health Enterprises IPO price

The price range of the issue is set at ₹560 to ₹590 baht per share.

2. Manipal Health Enterprise IPO Date

The mainboard IPO is open for subscription on Wednesday, July 29, and will end on Friday, July 31.

3. Manipal Health Enterprises IPO size

Manipal Health IPO is a fresh issue of 13.56 crore shares to be raised ₹8,000 crore, and an offer for sale (OFS) of 2,16,13,834 shares, totaling ₹1,275.22 billion.

4. Manipal Health Enterprises IPO subscription

75% of the net issue is reserved for qualified institutional buyers (QIBs), and 15% of the net issue is reserved for non-institutional investors (NIIs). The remaining 10% is reserved for retail investors.

5. Manipal Health Enterprises IPO size

The IPO share size is 25 shares. The minimum size for retail investors is one lot. With the highest price tag of the issue at ₹590, the minimum amount of investment required by retail investors is ₹14,750. The most common size for retail investors is 13 for ₹1,91,750.

6. Manipal Health Enterprises IPO lot book-running leader managers and registrar

Kotak Mahindra Capital Limited, Axis Capital Limited, Goldman Sachs (India) Securities Private Limited, Jefferies India Private Limited, JP Morgan India Private Limited, UBS Securities India Private Limited, and DBS Bank India Limited are the book-running managers, while KFin Technologies Limited is the registrar for the Manipal Health Enterprises IPO.

7. Manipal Health Enterprises IPO Allotment Date and Listing Date

While the IPO is closing on Friday, July 31, the allotment of shares is expected to be completed on the next business day, Monday, August 3. Successful bidders can receive their shares on the next working day, Tuesday, August 4, and those who are not allocated will be refunded the same day. Manipal Health Enterprises IPO will list on BSE and NSE on Wednesday, August 5.

8. Purpose of Manipal Health Enterprise IPO

According to RHP, the company will use the proceeds from the fresh share issue to repay certain loans and interest from its subsidiary, Manipal Hospitals. It will also be used to acquire a minority stake in its subsidiary, Sahyadri Hospital. A portion of the net income will be used for the general purpose of the company.

9. Business overview of Manipal Health

Manipal Health Corporation operates a network of multidisciplinary hospitals across India.

As of March 31, 2026, it operates 49 hospitals with 13,037 licensed beds across 14 states and union territories in India.

The company claims to be the largest hospital network in India by bed capacity and the second largest hospital chain by number of hospitals as on March 31, 2026.

10. Financial performance of Manipal Health

The company’s total income from operations is ₹6,171.63 billion in FY24, which increased to ₹8,242.25 billion in FY25 and up ₹10,335.75 billion in FY26. Its profit ₹594.32 billion in FY24, ₹1,065.36 crore in FY25, and ₹892.32 billion in FY26.

Read all the news related to the market here

Read more stories by Nishant Kumar

Disclaimer: This article is for educational purposes only and does not constitute investment advice. The views and recommendations expressed are those of the individual analyst or brokerage firm, not Mint. We advise investors to consult with a certified professional before making an investment decision, as market conditions can change rapidly and circumstances may vary.